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Staphylococcus aureus biofilms are extremely difficult to treat. They provide a protected niche for the bacteria, rendering them
highly recalcitrant toward host defenses as well as antibiotic treatment. Bacteria within a biofilm are shielded from the immune
system by the formation of an extracellular polymeric matrix, composed of polysaccharides, extracellularDNA (eDNA), and pro-
teins.Many antibiotics do not readily penetrate biofilms, resulting in the presence of subinhibitory concentrations of antibiotics.
Here, we show that subinhibitory concentrations of clindamycin triggered a transcriptional stress response in S. aureus via the
alternative sigma factor B (B) and upregulated the expression of the major biofilm-associated genes atlA, lrgA, agrA, the psm
genes, fnbA, and fnbB. Our data suggest that subinhibitory concentrations of clindamycin alter the ability of S. aureus to form bio-
films and shift the composition of the biofilmmatrix toward higher eDNA content. An understanding of the molecular mecha-
nisms underlying biofilm assembly and dispersal in response to subinhibitory concentrations of clinically relevant antibiotics
such as clindamycin is critical to further optimize antibiotic treatment strategies of biofilm-associated S. aureus infections.
Staphylococcus aureus is a major cause of both health care-re-lated and community-associated (CA) infections. The Gram-
positive human-pathogenic bacterium produces and secretes a
range of toxins and enzymes leading to acute infections such as
bacteremia and skin abscesses (1, 2). In addition, most S. aureus
strains are capable of biofilm formation and can persist in host
tissues such as the bone, leading to chronic osteomyelitis, or on
implanted medical devices such as vascular catheters, vascular
grafts, heart valves, and prosthetic joints (3–5). Biofilm-associated
infections are extremely difficult to treat, and these chronic or
relapsing infections typically require prolonged antibiotic treat-
ment or removal of the device (6–8). Antibiotic resistance of bac-
teria within a biofilm may result from slow growth, phenotypic
heterogeneity, persister cell formation, and inactivation or re-
duced penetration of the antibiotic (9, 10). Diffusion of the anti-
biotic through biofilm cell clusters is dependent on the thickness
and the composition of the extracellular polymeric matrix (9, 11).
The slow transport within biofilms suggests that the bacteria may
encounter subinhibitory concentrations of antibiotics. Previous
studies have shown that low doses of different antibiotics trigger
biofilm formation (12, 13) and lead to dramatic alterations in
bacterial gene expression in S. aureus (14).
Biofilm formation proceeds in at least three phases: initial at-
tachment, biofilm maturation, and dispersal (15, 16). Initial sur-
face attachment is dependent on bacterial surface molecules such
as the S. aureus murein hydrolase AtlA, teichoic acids, and fi-
bronectin-binding proteins (FnBPs) (17–20). After attachment to
the surface, the bacteria multiply and produce the extracellular
polymeric matrix. Various studies showed that the biofilmmatrix
of many laboratory and clinical staphylococcal isolates is com-
posed of substantial quantities of extracellular DNA (eDNA) (21–
23)which is counterbalanced by the effect of the bacterial nuclease
Nuc1 (24, 25). The negatively charged DNA plays an important
role during attachment and biofilm maturation, potentially
through its electrostatic properties (26). The release of eDNA into
the biofilm matrix is dependent on murein hydrolases (19, 27).
AtlA, the major autolytic enzyme in S. aureus, is required for cell
division, cell wall turnover, and bacterial lysis (28, 29). Autolysis
in S. aureus biofilms is also regulated by the activity of the Cid/Lrg
holin-antiholin system. CidA oligomerizes in the bacterial cell
membrane and increases the activity of murein hydrolases, possi-
bly by exporting them into the extracellular space (22, 30, 31). In
the dispersal phase, bacteria detach from the biofilm and spread to
new infection sites. A quorum-sensing system (Agr) is responsible
for the switch between biofilm formation and detachment (32,
33). Recently, it was shown that the quorum-sensing-controlled
phenol-soluble modulins (PSMs) (34, 35) are present in biofilms
as large amyloid fiberswhich, under certain conditions, stabilize S.
aureus biofilms (36) but also play a role in biofilm dispersal due to
their surfactant-like properties (34, 37).
There is growing evidence that S. aureus specifically responds
to subinhibitory antibiotic concentrations by inducing biofilm
formation and changing its biofilm matrix composition (38).
Clindamycin (CLI), a protein synthesis inhibitor used in the treat-
ment of Gram-positive bacterial infections, modulates the pro-
duction of several toxins and virulence factors in S. aureus (14,
39–43). Recently, it was also shown that the production and ex-
pression of PSMs are significantly increased in planktonic S. au-
reus cultures by subinhibitory concentrations of clindamycin (44,
45). Clindamycin achieves high intracellular levels in bones and
phagocytic cells and potentiates opsonization and phagocytosis at
subinhibitory concentrations (46, 47). However, the impact of
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subinhibitory concentrations of clindamycin on the biofilm for-
mation and matrix composition of clindamycin-sensitive S. au-
reus has not been investigated so far.
It is evident that during antibiotic treatment, host tissues,
wounds, and biofilm-infected medical devices are exposed to a
range of antibiotic concentrations. Here, we examined whether
the exposure of S. aureus to subinhibitory concentrations of clin-
damycin modulates biofilm formation and changes the matrix
composition in the community-acquired methicillin-resistant S.
aureus (CA-MRSA)USA300 LAC strain (LACwild type [wt]) and
its isogenic mutants as well as clinical isolates (CIs). This study
provides a deeper understanding of the modulation and regula-
tion of S. aureusmatrix components in response to subinhibitory
concentrations of clindamycin, a commonly used antibiotic in
clinical settings.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains and plas-
mids used in this study are listed in Tables S1 to S3 in the supplemental
material. Bacterial strains were grown on blood agar plates (Columbia
agar plus 5% sheep blood; bioMérieux SA). Brain heart infusion (BHI)
broth (BD Difco) supplemented with 0.4% glucose (wt/vol; BHIg) was
used for all overnight cultures (220 rpm, 37°C) and static biofilm assays
with clindamycin hydrochloride (AppliChem GmbH) or amoxicillin
(Sigma-Aldrich). TheMIC of clindamycin in BHIg broth was determined
as previously described (41). The MIC for the LAC wt, the isogenic mu-
tants, and the clinical isolates CI-1 to CI-8, CI-11, and CI-12 was 0.125
mg/liter in BHIg broth. TheMIC for CI-9 was 0.06mg/liter, and for CI-10
it was 0.03 mg/liter. All clindamycin-resistant clinical isolates (CI-13 to
CI-18) showed visible growth up to 256 mg/liter of clindamycin in BHIg
broth (MIC 256 mg/liter). Antibiotics were used at the following con-
centrations: erythromycin at 10 g/ml (Erm), chloramphenicol at 10
g/ml (Cm), and ampicillin at 100 g/ml (Amp).
To assess any effect that might be due to the genetic background of the
strains, sequence typing of the polymorphic repeat region of the protein A
gene (spa) (48) was performed using Ridom StaphType software (Ridom
GmbH, Würzburg, Germany).
Construction of S. aureusmutants. Phage11 was used to transduce
all knockout mutations into the LAC wt background. The agr::tet(M)
mutation was transduced from S. aureus strain RN6911 (49) into LAC.
The generated strain LAC agr::tet(M) had a complete deletion of the agr
locus, which was confirmed by sequencing using the primers agrlocus-F
and agrlocus-R (see Table S2 in the supplemental material). The strains
NE1438, NE1692, and NE460 from the Nebraska Transposon Mutant
Library were obtained from the Network on Antimicrobial Resistance in
Staphylococcus aureus (NARSA) repository (50). The mutants carry the
bursa aurealis mariner-based erythromycin resistance-expressing trans-
poson (Tn) within the lrgA (SAUSA300_0256), cidA (SAUSA300_2479),
or atlA (SAUSA300_0955) gene and were used to introduce mutations
into LAC wt by phage transduction. To delete the erm cassette of the S.
aureusLAC transposonmutants, we used allelic exchange via homologous
recombination of the bursa aurealis Tn insertions (51). Briefly, the trans-
poson mutants were transformed with the plasmid pTnT carrying a
500-bp homologous region 5= and 3= of the bursa aurealis Tn and a chlor-
amphenicol resistance marker. Strains carrying the plasmid were incu-
bated overnight on chloramphenicol (Cm) agar plates. The next day the
colonies were restreaked, and after an additional overnight incubation on
Cm agar plates at 44°C, the colonies representing single recombinants
were used for further subculturing steps at 30°C without antibiotic. An-
hydrotetracycline (ATc; 100 ng/ml) was used as counterselection because
it inhibits growth of cells still carrying the plasmid. Colonies which had
lost the plasmid (Cm sensitive) were screened on Erm agar plates for
double recombination. The erm cassette deletion was confirmed by PCR
using the primer pairs cidA/Buster, atlA/Upstream, and lrgA/lrgA-R and
by sequencing with the primers listed in Table S2 in the supplemental
material.
Biofilm experiments. Bacterial strains were grown overnight on fresh
blood agar plates, resuspended in phosphate-buffered saline (PBS; Kan-
tonsapotheke Zurich, Switzerland), and diluted in BHIg broth. A total of
180 l of BHIg broth with or without clindamycin or amoxicillin was
transferred to a polystyrene 96-well plate (Cellstar; Greiner), and 20 l of
diluted bacteria (final concentration, about 5 105 CFU/ml) or medium
(blank) was added before incubation for 18 h at 37°C in a wet chamber
unless otherwise indicated. After incubation, the wells were rinsed three
times with 200l of PBS, air dried, and stainedwith 0.1% crystal violet for
30 min. Unbound dye was removed by three washes with distilled water.
The adhering dye was dissolved with 30% acetic acid, and the absorption
wasmeasured at 570 nmwith aVersaMaxmicroplate reader and SoftMax
Pro, version 4.3.1 LS, software (Molecular Devices). Biofilm assays in
12-well polystyrene plates (Cellstar; Greiner Bio-One) used for RNA iso-
lation, viable bacteria count (CFU/ml), and eDNA analysis were done as
described above with 7.5-fold more volume per well.
qRT-PCR analysis. Transcripts from LAC wt and atlA mutant bio-
films cultured with or without subinhibitory concentrations of clindamy-
cin were assayed by quantitative reverse transcription-PCR (qRT-PCR).
After 18 h of incubation in a 12-well polystyrene plate, S. aureus biofilm of
LAC wt was washed three times with PBS and scraped off with a cell
scraper. An aliquot was used for determination of CFU counts per milli-
liter. The biomass from two wells was pooled and spun down at 12,000
g at 4°C for 5 min. RNA isolation and qRT-PCR were performed as pre-
viously described (41). All primers used for qRT-PCR are listed in Table
S2 in the supplemental material. Differences in mRNA levels were calcu-
lated as follows: the CT (where CT is cycle threshold) values of gyrB and
the genes of interests were calculated by normalization of the mean CT
from each biological replicate to the median of the biological replicates
without CLI. For each sample, the fold changewas calculated according to
the Pfaffl analysismethod (52). PCR experimentswere performedusing at
least three biological replicates, each tested in technical triplicates.
Isolation andquantificationof extracellularDNA.Bacteriawere cul-
tured in 12-well plates in BHIg broth with or without subinhibitory con-
centrations of clindamycin (0.06 g/ml). After 18 h of incubation, the
supernatant was removed, and the biofilm was washed three times with
PBS to remove planktonic cells. Five hundred microliters of PBS was
added, and the cells were scraped from the surface using a cell scraper. The
cells were transferred to a 1.5-mlmicrocentrifuge tube and sonicated in an
ultrasonic bath (XUBA3; Grant). To degrade components of the biofilm
matrix to release eDNA, the samples were incubated for 30 min at 37°C
with 1 l of peptide-N-glycosidase F ([PNGase F] 500 U/l; NEB) and
then with proteinase K (final concentration, 5g/ml; Sigma-Aldrich). An
aliquot was used for determination of the CFU count per milliliter. After
filtration (0.22-m-pore-size polyvinylidene difluoride [PVDF] filter; Mil-
lipore), 1 volume of phenol-chloroform-isoamyl alcohol (25:24:1; Sigma-
Aldrich) was added, and the mixture was vortexed and centrifuged at
10,000  g for 10 min. The upper phase was collected, and eDNA was
precipitated by addition of 1/10 volume of 3 M sodium acetate (Sigma-
Aldrich) and 2.5 volumes of 100% ethanol (Sigma-Aldrich). After over-
night precipitation at 20°C, centrifugation at 20,000  g for 10 min at
4°C, andwashes with ice-cold 70% ethanol, the eDNApellet was air dried,
resuspended in Tris-EDTA (10:1) buffer, and quantified using a Nano-
Drop 2000 spectrophotometer (Thermo Fisher Scientific). The eDNA
amount was calculated relative to the mean biofilm mass of a 12-well
polystyrene plate. eDNA was separated on a 0.8% agarose gel (0.5 g/ml
ethidium bromide) and visualized with a Benchtop UV Transilluminator
(UVP, Axon Lab) and TS Image software (UVP).
Zymogram assays. S. aureus LAC wt and atlA overnight cultures
grown in BHIg broth without or with (0.03 and 0.06 g/ml) clindamycin
were set to the same optical densities at 600 nm (OD600) and centrifuged
at 4,000  g at 4°C for 10 min. The supernatant was filtered (0.45-m-
pore-size PVDF filter; Millipore) and stored at80°C. Pellets were resus-
Schilcher et al.
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pended in PBS (pH 8) containing protease inhibitor (cOmplete protease
inhibitor cocktail tablet; Roche). After incubation at 4°C for 1 h, cells were
pelleted as described above and resuspended in 200l of PBS (pH 8) plus
2% SDS. Cells were incubated at 37°C for 20 min, followed by centrifuga-
tion (10,000  g, 4°C). Protein concentrations of the crude cell wall ex-
tracts (SDS extracts) were determined by a bicinchoninic acid (BCA) pro-
tein assay (Bio-Rad Laboratories, Inc.) according to the manufacturer’s
instructions. Murein hydrolase activities in the crude cell wall extract and
the supernatant were analyzed by zymographic analysis. Ten micrograms
of total protein from crude cell wall extracts and 13 g of total protein
from supernatants were separated using a 10% acrylamide gel containing
about 100mg of pellet (wet weight) of heat-inactivatedMicrococcus luteus
or S. aureusRN4220with an electrophoresis system (Bio-Rad). After elec-
trophoresis, the gels were incubated in the reaction buffer (25 mM Tris-
HCl [pH8], 1%TritonX-100) for at least 18 h, statically at 37°C.Gelswere
imaged with an Epson Perfection V700 photo scanner (Epson). Contrast
and brightness were enhanced with IrfanView software.
Extraction of staphyloxanthin. LAC wt and clinical isolates were
grown in BHIg broth at 37°C in petri dishes (94 by 16 mm, Cellstar;
Greiner) for 18 h. The supernatant was removed and after washes with
PBS, the biofilm was scraped off with a cell scraper, followed by centrifu-
gation (10,000  g for 10 min) and washing with double-distilled H2O
(ddH2O). Pictures of pelleted bacteria were enhanced for contrast and
brightness with IrfanView software. Methanol (Sigma-Aldrich) extrac-
tion of staphyloxanthin was performed as described by Morikawa et al.
(53). Absorption was measured at 465 nm with a VersaMax microplate
reader and Soft Max Pro, version 4.3.1 LS, software (Molecular Devices).
Surfactant activity. A drop-collapse assay was used as semiquantita-
tive measurement of surfactant activity. The reduction of surface tension
causes a collapse of the drop on a hydrophobic surface (Parafilm). Bacte-
ria (LAC wt, agr, and atlA strains) were cultured with shaking or under
static conditions in a 96-well plate in BHIg broth with or without clinda-
mycin (0.03 and 0.06 g/ml) at 37°C for different time periods. After
incubation, shaking cultures or the supernatant of the 96-well plate were
spun down at 8,000 g for 15min. Fifty-microliter dropswere spotted on
Parafilm and imaged with an Epson Perfection V700 photo scanner
(Epson).
Electron microscopy. LAC wt and the atlA mutant were grown in
BHIg broth with and without clindamycin (0.06 g/ml) for 18 h at 37°C.
Bacteria were fixed in 2.5% glutaraldehyde in 0.1M cacodylate buffer and
postfixed in 1% osmium tetroxide and then 1% aqueous uranyl acetate.
After stepwise dehydration in 70, 80, and 100% ethanol followed by pro-
pylene oxide, samples were embedded in Epon 30 and thin sectioned.
Samples were poststained according to the Reynolds lead staining proce-
dure. Images were taken with a 100 kV transmission electron microscope
(TEM) with a digital charge-coupled-device (CCD) camera (TEMPhilips
CM100).
spa typing of clinical isolates. Sequence typing of the polymorphic
repeat region of the protein A gene (spa) (48) was performed using Ridom
StaphType software (Ridom GmbH, Würzburg, Germany). Primers for
spa typing are listed in Table S2 in the supplemental material.
Statistics. Data were analyzed by using a Mann-Whitney U test for
single comparisons or a Kruskal-Wallis test followed by post hoc Dunn’s
multiple comparisons. P values were calculated by using GraphPad Prism
(version 5), and differences were considered significant for P values
of0.05.
RESULTS
Increased amount of biofilm formation and eDNA by S. aureus
USA300 LAC in the presence of subinhibitory concentrations of
clindamycin.We assessed the impact of subinhibitory concentra-
tions of clindamycin on biofilm formation. Growth of S. aureus
LACwt in the presence of subinhibitory concentrations of clinda-
mycin led to an increase in the static biofilm mass after 18 h of
growth in a microtiter plate. The most pronounced increase in
biofilm mass occurred in the presence of 0.06 g/ml clindamycin
(Fig. 1A). The viable LACwt bacteria counts (numbers of CFUper
milliliter) from the biofilm mass after 18 h showed no significant
difference when bacteria were grown with various subinhibitory
concentrations of clindamycin (see Fig. S1A in the supplemental
material). As eDNA is a major matrix component andmight con-
tribute to the increased biofilm mass, we analyzed the amount of
eDNA in clindamycin-exposed biofilm cultures and compared the
amount to that of controls grown without clindamycin. When
normalized to the total biofilm mass, larger amounts of eDNA
were detected in biofilms cultured with clindamycin than in the
respective control without clindamycin (Fig. 1B). The isolated
eDNA contained high-molecular-weight DNA (Fig. 1C), as de-
scribed previously (12).
Since the Nuc1 nuclease and the Agr quorum-sensing system
are important for biofilm development and dispersal, we also
tested isogenic mutants deficient in nuc1 and the agr locus (25,
33). The nuc1 and agrmutants showed a higher total biofilmmass
than the wt after 18 h of incubation (see Fig. S1B in the supple-
mental material). In a next step, we evaluated the influence of
subinhibitory clindamycin concentrations on biofilm formation
in both mutants. In the nuc1 strain, the clindamycin-induced in-
crease in biofilm mass was similar to the level of the wt strain,
whereas no increase was observed in the agr mutant (Fig. 1A).
Viable bacteria counts of both mutants grown with or without
FIG 1 Modulation of biofilm formation and eDNA release in S. aureus LAC in
response to subinhibitory concentrations of clindamycin. (A) Quantification
of the biofilmmass of the LACwt,nuc1, and agr strainswith crystal violet in the
absence and presence of subinhibitory concentrations of clindamycin (CLI)
after 18 h of static incubation. Biofilm mass without clindamycin was set to 1,
and fold changes are presented. Results presented are average data from at least
three replicates 	 standard error of the mean. (B) eDNA isolated from bio-
films grown for 18 h from wt and mutants (nuc1 and agr strains) grown in the
presence of clindamycin were normalized to the biofilm mass, and results are
presented as fold change relative to the level of the control without clindamy-
cin. Results are average data from three replicates 	 standard error of the
means. (C) Representative agarose gel of isolated eDNA from biofilms incu-
bated with (
; 0.06 g/ml CLI) and without () clindamycin. Lane c, S.
aureus wt chromosomal DNA control ( 60 ng). A Gene Ruler 1-kb DNA
ladder is shown in the leftmost lane.
Impact of Clindamycin on S. aureus Bioﬁlm
October 2016 Volume 60 Number 10 aac.asm.org 5959Antimicrobial Agents and Chemotherapy
 o
n
 D
ecem
ber 5, 2016 by UZH Hauptbibliothek / Zentralbibliothek Zuerich
http://aac.asm
.org/
D
ow
nloaded from
 
clindamycin (0.06 g/ml) remained stable (see Fig. S1C). Similar
to the wt strain, both mutants had larger amounts of eDNA in
their biofilms when cultured with clindamycin than the biofilms
of the respective controls without clindamycin (Fig. 1B and C). As
the agr mutant did not show a clindamycin-induced increase in
biofilm mass in the static biofilm assay (Fig. 1A), we concluded
that the observed increased biofilm mass of the wt and nuc1 mu-
tant in response to subinhibitory concentrations of clindamycin
did not result only from increased amounts of eDNA in the extra-
cellular matrix.
Elevated biofilm formation by the S. aureus USA300 LAC
autolysis mutant atlA in the presence of clindamycin. The ob-
served increase in eDNA led us to investigate whether S. aureus
autolysis systems (AtlA andCidA/LrgA) are involved in clindamy-
cin-induced changes of the biofilm matrix. We confirmed that
deletion of atlA significantly impaired biofilm formation (see Fig.
S1B in the supplemental material) (19). When we cultured the
isogenic atlA mutant in the presence of subinhibitory concentra-
tions of clindamycin, we observed an up to 3.5-fold increase in the
biofilm mass with 0.03 and 0.06 g/ml of clindamycin (Fig. 2A).
In addition, the atlA mutant strain cultured with clindamycin
(0.06g/ml) showed an approximately 3-fold increase in the CFU
count per milliliter in the biofilm mass (see Fig. S1C). The lrgA
mutant grown without clindamycin resulted in increased biofilm
accumulation compared to the level in the wt strain (see Fig. S1B).
In contrast to results in a previous study by Rice et al. (22), dele-
tion of cidA did not impair biofilm formation in our biofilm set-
ting after 18 h but did produce an increase in biofilmmass (see Fig.
S1B). No clindamycin-induced alteration of the biofilm pheno-
type was observed in the cidA and lrgAmutants (Fig. 2A).
When we calculated the amount of eDNA relative to the bio-
film mass, the atlA mutant showed a negative fold change of
eDNA after exposure to subinhibitory concentrations of clinda-
mycin compared to the level in the control (Fig. 2B). In contrast, a
modest increase in eDNA in the extracellular biofilm matrix was
observed in the lrgA and cidA mutants (Fig. 2B), and the isolated
eDNA of all three mutant strains contained high-molecular-
weight DNA (Fig. 2C). We concluded that CidA and LrgA are not
essential for clindamycin-induced eDNA release in our biofilm
model.
Mlynek and colleagues showed that subinhibitory concentra-
tions of the -lactam antibiotic amoxicillin induced biofilm for-
mation in the USA300 wt and a nuclease-deficient mutant, while
no alteration of biofilm formationwas observed in an atlAmutant
(54). To compare our biofilm model with these previously pub-
lished data on antibiotic-induced biofilm alterations, we also
tested the influence of amoxicillin on biofilm formation. In agree-
ment with Mlynek and colleagues, we observed amoxicillin-me-
diated induction of biofilm formation for the USA300 LAC wt as
well as the nuc1 background, and no induction was observed for
the atlAmutant background (see Fig. S2 in the supplemental ma-
terial).
Upregulation of genes involved in stress response, attach-
ment, and eDNA release by clindamycin. To corroborate our
functional biofilm assay, we investigated the effect of subinhibi-
tory clindamycin concentrations on the expression of genes in-
volved in autolysis, stress response, and attachment. cDNA levels
derived from RNA of 18-h biofilms grown with and without clin-
damycin were quantified by real-time PCR (qRT-PCR). As shown
in Fig. 3A, expression of atlA and lrgAwas upregulated in response
to subinhibitory concentrations of clindamycin while cidA and
nuc1 expression was not affected.
As subinhibitory concentrations of antibiotics can induce a
general stress response (38, 55), gene expression of the alternative
sigma factor B (B) was investigated in our biofilm model and
showed an upregulation of 3- and 7-fold in response to 0.03 and
0.06g/ml clindamycin, respectively (Fig. 3B). Since the S. aureus
carotenoid pigment staphyloxanthin is positively regulated by B
(56, 57), we quantified the amount of staphyloxanthin of the LAC
wt in response to subinhibitory concentrations of clindamycin
and amoxicillin in our biofilmmodel. We found that the amount
of staphyloxanthin increased with subinhibitory concentrations
of clindamycin but not with addition of amoxicillin (see Fig. S3A
and B in the supplemental material). As B upregulates adhesion
factors (58–60), we investigated the expression of the genes en-
coding the fibronectin binding proteins A (FnbA) and B
(FnbB). Transcript levels of fnbA and fnbB were clearly higher
in biofilms grown in the presence of 0.03 g/ml of clindamycin
(Fig. 3B).
Subinhibitory concentrations of clindamycin induce psm
gene expression and surfactant activity. In addition to eDNA
and the FnBPs, the recently discovered PSMs are important bio-
film matrix components which are able to stabilize S. aureus bio-
films but also play a role in biofilm dispersal (34, 36, 37). Tran-
scription of the psm genes is under the control of the AgrA DNA
binding protein (35). Thus, we studied the effect of subinhibitory
FIG 2 Subinhibitory concentrations of clindamycin affect an S. aureus auto-
lysinmutant. (A)Quantification of the biofilmmass of the LAC atlA, cidA, and
lrgA mutants with crystal violet in the absence and presence of subinhibitory
concentrations of clindamycin (CLI) after 18 h of static incubation. Biofilm
without clindamycin was set to 1, and fold changes are presented. Results
presented are average data from at least three replicates	 standard error of the
means. (B) eDNA isolated from biofilms grown for 18 h from LAC mutants
(atlA, cidA, and lrgA strains) grown in the presence of clindamycin were nor-
malized to the biofilmmass and presented as fold change relative to the control
without clindamycin. Results are average data from three replicates 	 stan-
dard error of the mean. (C) Representative agarose gel of isolated eDNA from
biofilms incubated with (
; 0.06 g/ml CLI) and without () clindamycin.
Lane c, S. aureuswt chromosomal DNA control ( 60 ng). A Gene Ruler 1-kb
DNA ladder is shown in the leftmost lane.
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concentrations of clindamycin on gene expression of agrA, the
psm operon (psm1-psm4), and the two genes of the psm
operon (psm1 and psm2) in our biofilm system. The expression
of agrA was upregulated 2.5-fold in the presence of clindamycin
(0.06 g/ml), and the upregulation of psm1-psm4 as well as of
psm1 and psm2 was even more pronounced (up to 60-fold)
(Fig. 4A). We also tested the induction of psm transcription in an
atlA mutant background, which showed the same clindamycin-
induced upregulation of psm genes as observed in the wt strain
(see Fig. S4 in the supplemental material). PSMs were shown to
exhibit surfactant-like activities (61), which lower the surface ten-
sion of liquids. In order to assess the functional effect of the highly
upregulated psm transcription, we used a drop-collapse assay to
illustrate the differences in surface tension of supernatants from
biofilms or bacterial cultures grown with and without clindamy-
cin. Surface tension was low in supernatants from bacterial over-
night cultures of LACwt and the atlAmutant, irrespective of clin-
damycin treatment (Fig. 4B). In contrast, surface tensionwas high
in biofilm supernatants after 18 h. After 36 h the biofilm superna-
tant of the atlA mutant showed a decrease in surface tension in
response to 0.06 g/ml of clindamycin. In the supernatant of a
54-h old biofilm, the surface tension of the wt strain was clearly
decreased in response to clindamycin compared to that of the
control. As PSM transcription was highly induced in the wt strain
and the atlA mutant by clindamycin, the observed decrease in
surface tension in these two strains might derive from PSM over-
production. No surfactant activity was detected in the superna-
tants of the agr mutant strain, indicating that the observed de-
FIG 3 Impact of subinhibitory concentrations of clindamycin on the expres-
sion of biofilm-associated genes. Relative transcript levels of genes important
for eDNA and autolysis (A) or stress response and adhesion (B) derived from
LAC wt biofilm mass with and without clindamycin after 18 h as determined
by qRT-PCR. Fold change ratios were calculated by normalizing cDNA levels
of the gene of interest against the housekeeping gene gyrB. Data are presented
as fold change compared to levels in biofilms grown without clindamycin (set
to 1), and error bars indicate interquartile range of at least three independent
experiments. The dotted line indicates a 2-fold upregulation.
FIG 4 Overexpression of the psm genes and increase in surfactant activity in S. aureus biofilms in response to clindamycin. (A) Relative transcript levels of agrA
and the psm genes derived from LAC wt biofilm mass after 18 h with and without clindamycin as determined by qRT-PCR. Fold change ratios were calculated
by normalizing cDNA levels of the gene of interest against the housekeeping gene gyrB. Data are presented as fold change compared to biofilms grown without
clindamycin (set to 1), and error bars indicate interquartile range of at least three independent experiments. The dotted line indicates a 2-fold upregulation. (B)
Surface tension of supernatants of a bacterial liquid culture and of biofilms grown for indicated time with and without clindamycin is illustrated by a
drop-collapse assay. If surfactants were present in the drop, the surface tension was reduced, and the drops spread or collapsed (indicated by arrows). Surfactant
activity was high in the LACwt and the atlAmutant in shaking cultures after 18 h.Whengrownas a biofilm, the atlAmutant showed an increase in surfactant activity
in response to clindamycin after 36 h while the LACwt showed a similar effect after 54 h. Representative images of three independent experiments are shown.
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crease in surface tension is dependent on the quorum-sensing
system.
Difference in S. aureusUSA300LACmorphologydue to sub-
inhibitory concentrations of clindamycin. Previous studies
showed that the cell walls of staphylococci are thickened when
exposed to high concentrations of clindamycin (62, 63). There-
fore, we examined the effect of subinhibitory concentrations of
clindamycin on S. aureus cell morphology by transmission elec-
tronmicroscopy (TEM). Cells grown in the presence of clindamy-
cin (0.06 g/ml) lost their spherical cell shape and appeared in-
flated, potentially reflecting a stress response phenotype. We did
not see a thickening of the cell wall after 18 h of incubation with
clindamycin. However, we observed a “peeling off” of the cell wall
along with membrane-like fibers protruding from the bacterial
cells (Fig. 5A). As AtlA was shown to play an important role in cell
division and separation (28, 29), clindamycin-induced atlA ex-
pression (Fig. 3A) may contribute to the observed phenotype.
Therefore, we also examined the cell morphology of the atlAmu-
FIG 5 Subinhibitory concentrations of clindamycin change S. aureus cell morphology. (A) Representative transmission electron images of the LAC wt and atlA
mutant from cultures grown without and with clindamycin (0.06 g/ml CLI). Arrows highlight membrane-like fibers. Scale bar, 2 m. (B) Zymogram analysis
of the LACwt and atlAmutant autolytic activity from cultures grown for 18 hwithout andwith clindamycin (0.03 to 0.06g/ml CLI). Crude cell wall extract (left
panel) or filtered supernatants (right panel) were loaded on gels containing S. aureus RN4220 or Micrococcus luteus as the substrate. Bacteriolytic activity is
indicated by the dark bands on the opaque gel. Bands are assigned as follows (27, 77): Pro-Atl (138 kDa), Atl with full-length propeptide; Atl (115 kDa),
amidase plus glucosaminidase; PP-AM( 84 kDa), amidasewith propeptide; AM(62 to 65 kDa), amidase;GL (55 kDa), glucosaminidase; Atl-GLcat (36 kDa
and 38 kDa), glucosaminidase catalytic domain lacking repeat domain; Sle1/Aaa ( 32 kDa), S. aureus autolysin. Band size was estimated based on the PageRuler
prestained protein ladder. Representative gels of at least three independent experiments are shown.
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tant grown with and without clindamycin by TEM. In the atlA
mutant no apparent peeling-off phenotype was observed in re-
sponse to clindamycin (Fig. 5A). In conclusion, the AtlA upregu-
lation by clindamycin might be responsible for the observed peel-
ing-off phenotype of the cell wall. To investigate the influence of
clindamycin on AtlA hydrolase activity in more detail, we per-
formed zymogram analysis of the wt and the atlA mutant in re-
sponse to clindamycin. Micrococcus luteus or Staphylococcus au-
reus cells were used to differentiate between glucosaminidase (GL)
and amidase (AM) enzyme activity, respectively. Several autolytic
bands were seen with the wt strain because AtlA undergoes mul-
tiple proteolytic cleavage events which are absent in the atlAmu-
tant (Fig. 5B). The additional 32-kDamurein hydrolase Sle1 (64),
also referred to as Aaa (65), was present in the wt as well as in the
atlA mutant, as seen when Staphylococcus aureus was used as a
substrate within the gel. The crude cell wall extracts showed min-
imal enhanced autolytic activity in response to clindamycin (0.03
and 0.06 g/ml) compared to that of the control (Fig. 5B, left
panel). A more profound effect of clindamycin was observed for
the extracellular autolytic activity in the culture supernatants, in
particular, the GL activity seen with Micrococcus as a substrate
(Fig. 5B, right panel).
Alteration of biofilm formation by clindamycin in clinical
isolates. Since clindamycin is routinely used in clinics to treat S.
aureus infections, we investigated whether subinhibitory concen-
trations of clindamycin also altered biofilm formation in S. aureus
clinical isolates (strains are listed in Table S3 in the supplemental
material) in our static biofilmmodel. All 18 tested clinical isolates
formed a static biofilm (see Fig. S5). One out of five clindamycin-
sensitive, methicillin-sensitive S. aureus (MSSA) strains (CI-1 to
CI-5) showed a slight induction of biofilm formation when sub-
jected to clindamycin at subinhibitory concentrations (CI-2) (Fig.
6A). This strain was isolated from a foreign-body-associated in-
fection (vascular prosthesis infection), while the other four strains
were isolated from native tissue-associated infections (endocardi-
tis, panaritium, abscess, and wound infection). All seven clinda-
mycin-sensitiveMRSA strains (CI-6 toCI-12) showed a reduction
of biofilm-forming capacity upon clindamycin exposure (Fig. 6B).
We also tested six clindamycin-resistant MRSA strains for their
biofilm phenotype when subjected to clindamycin at concentra-
tions just below their MICs. Two out of six strains showed clinda-
mycin-dependent biofilm induction when challenged with 64 and
256 g/ml clindamycin (Fig. 6C). These two clinical isolates
(CI-16 and CI-17) were USA300 clones (spa type t008) (66), like
ourmodel strain LACwt, and had been isolated from skin and soft
tissue infections. The other four clindamycin-resistant strains
were of spa types t586 (n  2) and t032 (n  2) and showed no
clindamycin-dependent biofilm induction, but strains from each
of the two spa types showed similar behavior in response to clin-
damycin. This indicates that the clindamycin-dependent biofilm
phenotype might be more pronounced in certain S. aureus sub-
groups, like the USA300 clonal lineage.
FIG6 Impact of subinhibitory concentrations of clindamycin on S. aureus clinical isolates. Biofilmmass quantification ofMSSA clinical isolates CI-1 toCI-5 (A),
clindamycin-sensitive MRSA clinical isolates CI-6 to CI-12 (B), and clindamycin-resistant MRSA clinical isolates CI-13 to CI-18 (C) with crystal violet in the
absence and presence of subinhibitory concentrations of clindamycin (CLI) after 18 h of static incubation. Biofilm without clindamycin was set to 1, and fold
changes are presented. Results are average data from at least three replicates 	 standard error of the mean. *, highest tested clindamycin concentration, 0.03
g/ml (MIC, 0.06 g/ml); **, highest tested clindamycin concentration, 0.015 g/ml (MIC, 0.03 g/ml).
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We next investigated whether the biofilm phenotype of the
clinical isolates in response to clindamycin correlated with
staphyloxanthin production and was thereby associated with a
B response to clindamycin. We chose five representative
strains to quantify staphyloxanthin production, including two
MSSA strains, one showing a clindamycin-induced biofilm phe-
notype (CI-2) and one which did not show a response to clinda-
mycin (CI-4). Furthermore, we tested two clindamycin-sensitive
MRSA strains, neither of which showed biofilm induction by clin-
damycin (CI-6 and CI-8), and one clindamycin-resistant MRSA
strain which showed induction of biofilm formation upon clinda-
mycin exposure (CI-16). As shown in Fig. S3C and D in the sup-
plemental material, four out of five tested clinical isolates showed
an increase in staphyloxanthin production. Strains CI-4 and CI-6
showed clear induction of staphyloxanthin production upon clin-
damycin exposure but did not show an increase in biofilm forma-
tion. The clindamycin-resistant MRSA CI-16 (spa type t008;
USA300) showed the same biofilm and staphyloxanthin pheno-
type as our model strain LAC. These data indicate that the ob-
served clindamycin-induced biofilm phenotype of our tested clin-
ical isolates correlates with a B response to clindamycin in the
USA300 background but not in the other tested clinical isolates
that had distinct spa types.
DISCUSSION
In this study, we show that subinhibitory concentrations of the
frequently clinically used protein synthesis inhibitor clindamycin
induced biofilm formation and altered the biofilmmatrix compo-
sition of the CA-MRSA strain USA300 LAC. Although previous
studies have investigated the effect of several antibiotics at subin-
hibitory concentrations on staphylococcal biofilm formation and
matrix composition (12, 13, 38, 54, 67), the effect of subinhibitory
concentrations of clindamycin, an important antibiotic to treat S.
aureus infections, had not been investigated so far. Clindamycin-
mediated biofilm inductionwas observed in thewt strain aswell as
in the nuc1 and atlA mutants. In addition, clindamycin had no
effect on nuc1 expression. Taking these findings together, this
shows that the observed biofilm induction by clindamycin is not
due to transcriptional nuc1 repression. The atlAmutant was defi-
cient in biofilm formation, which is in agreement with the role of
AtlA in primary attachment (19, 28), and showed a 3.5-fold in-
duction of biofilm formation by clindamycin. The presence of
clindamycin also resulted in an increase of the viable bacteria
count in the atlA mutant. Therefore, the clindamycin-induced
increase in biofilm mass might derive from a combination of the
higher viable bacteria count in the biofilm and an increase in pri-
mary attachment to the plastic surface.
Glucose-induced biofilms in the USA300 LAC strain are
mainly polysaccharide intercellular adhesin (PIA) independent
(16, 68), and a major component of these biofilms is eDNA (19,
22, 23). In S. aureus biofilms, the eDNA is likely produced through
the autolysis of a subpopulation of cells which is mediated by the
murein hydrolase AtlA (27). Isolation of eDNA from biofilms
grown with and without clindamycin confirmed the presence of a
small amount of eDNA in the atlA mutant relative to the biofilm
mass. In contrast to results in the atlA mutant, clindamycin in-
creased the amount of eDNAwithin the biofilmmatrix in thewt as
well as in the other mutant strains (nuc1, agr, cidA, and lrgA
strains) relative to the biofilmmass. This suggests that the increase
in eDNA of the wt and nuc1 mutant only partially contributes to
the increase in biofilm formation. Clindamycin had no effect on
biofilm formation of the cidA and the lrgAmutants. In the absence
of clindamycin, we observed increased biofilm formation in the
lrgA mutant compared to that in the wt strain, as previously re-
ported for an S. aureusUAMS-1 lrgABmutant (24). Expression of
lrgAB is induced by the LytSR two-component system, which
senses a reduction in the membrane potential () (69). Al-
though in an earlier study a cidA mutant in S. aureus UAMS-1
exhibited decreased lysis resulting in smaller amounts of eDNA
and impaired biofilm formation (22, 24), the LAC cidA mutant
showed the same biofilm phenotype as the wt strain in our biofilm
model after 18 h. Transcription of cidA in UAMS-1 biofilms
steadily increased over time (up to 90-fold after 72 h) (70). There-
fore, its effect on biofilm formation might play only a minor role
in our 18-h-old biofilm systemwhile LrgABmight be activated by
changes in the membrane potential at an earlier time point.
The atlA gene expression was approximately 25-fold upregu-
lated in response to subinhibitory concentrations of clindamycin,
which is themost likely cause of the observed increase of eDNA in
the biofilm. We did not detect a difference in cidA expression but
an upregulation of agrA and lrgA in response to clindamycin. The
lrgAB operon is positively regulated by the Agr system and by
the transcriptional regulator SarA (71), which was shown to be
upregulated in response to clindamycin (14). Therefore, the
observed upregulation of lrgA is likely due to the clindamycin-
derived upregulation of these regulators. Since subinhibitory
concentrations of clindamycin highly induced biofilm forma-
tion in the atlA mutant strain, we speculate that additional fac-
tors, likely fibronectin-binding proteins (FnBPs), are upregulated
that might compensate for the impaired attachment of the atlA
mutant strain. FnBPs mediate intercellular cell-cell adhesion via
homophilic bonds (72) and are required for primary attachment
and biofilm accumulation in the USA300 LAC strain (20). Cor-
roborating this, we observed an upregulation of fnbA and fnbB
expression by clindamycin in the biofilm. It has previously been
shown that the S. aureus strain Newman showed increased
amounts of fnbB transcripts due to selective mRNA stabilization
in response to clindamycin (73).
The observed alteration in the expression profile in response to
subinhibitory concentrations of clindamycin might be due to the
activation of a general stress response via the alternative sigma
factor B (B). We confirmed that sigB expression was upregulated
and that significantly larger amounts of B-dependent staphylox-
anthin were isolated in response to clindamycin. B controls a
large regulonwhich includes the expression of fnbA and fnbB (58–
60) as well as atlA in certain S. aureus strains (19).
In contrast to the results obtained with our model strain
USA300 LAC, the B-dependent staphyloxanthin production
correlated with the observed biofilm phenotypes in only two
out of five selected clinical isolates. This indicates that the clin-
damycin-induced B stress response does not necessarily trans-
late into elevated biofilm formation. In addition, the observed
amoxicillin-dependent biofilm induction was not associated
with staphyloxanthin production. These experiments indicate
that antibiotic-induced biofilm formation might derive from a
B-dependent stress response in only certain clonal lineages
(USA300). At the same time, aB-dependent stress response is not
a necessary prerequisite for antibiotic-induced biofilm formation.
Other important matrix components which were recently dis-
covered to play a role in S. aureus biofilm formation and dispersal
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are PSMs (74). The formation of amyloid fibers is thought to
contribute to S. aureus biofilm integrity under certain conditions
andmight serve as a storagemechanism until the surfactant activ-
ity of themonomeric PSMpeptides is required (36, 37). The psm
and psm genes are highly induced by subinhibitory concentra-
tions of clindamycin in our biofilmmodel. In addition, surfactant
activity increased in the supernatant of a 36-h-old atlA mutant
biofilm and after 54 h also in the wt strain in response to clinda-
mycin. The presence of eDNA in the biofilm matrix facilitates
PSMs to form amyloid fibers (75). As we observed induction of
psm gene expression and eDNA release in our biofilm model, we
speculate that the formation of amyloid fibers might be increased
at early time points (18 h) when we observed a thick biofilm with
large amounts of eDNA. At later time points, degradation of
eDNA and decomposition of the fibers might lead to biofilm
dispersal via surfactant activity of the PSM monomers. Defi-
cient release of eDNA in the atlA mutant might therefore hin-
der eDNA-mediated amyloid fiber formation of PSMs and
thereby contribute to the observed surfactant activity at early time
points in the mutant.
In summary, we showed that subinhibitory concentrations of
clindamycin have diverse effects on S. aureus biofilm formation
which highly depend on the strain background. In-depth analysis
of the model strain LAC wt from the USA300 clonal lineage
showed that subinhibitory concentrations of clindamycin alter the
biofilm matrix composition by changing autolysis and eDNA re-
lease, increasing adhesion factors and secreted proteins, which
likely leads to an interaction between the matrix components.
Previous studies showed that biofilm matrix components bind to
each other and act as an electrostatic network by connecting cells
within the biofilm (26, 76). We hypothesize that the clindamycin-
induced matrix components such as eDNA, PSMs, and FnbBs are
highly interconnected within the biofilm matrix, which might re-
sult in a more compact and stable biofilm. Since the increase in
biofilm formation and alteration of thematrix compositionmight
impact S. aureus biofilm-associated infections, clindamycin
should be dosed as high as possible in order to prevent subinhibi-
tory clindamycin concentrations in affected tissues and biofilms.
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